{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:05:19Z","timestamp":1790946319714,"version":"4.1.0"},"reference-count":16,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> A small proportion of patients in need of transcatheter aortic valve replacement (TAVR) are not suitable for the transfemoral approach due to peripheral artery disease. Alternative TAVR approaches are associated with short- and long-term hazards. A novel technique of caval-aortic (transcaval) access for TAVR has been utilized as an alternative access technique.<\/jats:p><jats:p><jats:bold>Aim:<\/jats:bold> To compare safety and efficacy of transcaval access as compared to other alternative access (axillary or apical) for TAVR.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A single-center, retrospective analysis of consecutive patients undergoing alternative access for TAVR. Events were adjudicated according to VARC-2 criteria.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 185 patients were included in the present analysis. Mean age was 81 years with a small majority for male gender (54%). Of the entire cohort, 20 patients (12%) underwent transcaval TAVR, and 165 patients (82%) underwent TAVR using alternative access. Overall, baseline characteristics were comparable between the two groups. General anesthesia was not utilized in transcaval patients; however, it was routinely used in nearly all alternative access patients. TAVR device success was comparable between the two groups (95%). Acute kidney injury occurred significantly less frequently among transcaval patients as compared to alternative access patients (5 vs. 12%, <jats:italic>p<\/jats:italic> = 0.05). Hospital stay was shorter for transcaval patients (6.3 days vs. 14.4; <jats:italic>p<\/jats:italic> &amp;lt; 0.001). No difference in early or 30-day mortality (10 vs. 7.9%, <jats:italic>p<\/jats:italic> = 0.74) was noted between groups.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> In patients who cannot undergo TAVR <jats:italic>via<\/jats:italic> the trans-femoral approach due to peripheral vascular disease, transcaval access is a safe approach as compared to other alternative access techniques, with lower risk of kidney injury and shorter hospital stay.<\/jats:p>","DOI":"10.3389\/fcvm.2021.731639","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T05:15:10Z","timestamp":1632287710000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical Outcome and Safety of Transcaval Access for Transcatheter Aortic Valve Replacement as Compared to Other Alternative Approaches"],"prefix":"10.3389","volume":"8","author":[{"given":"Israel M.","family":"Barbash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Berkovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Maor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Elian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Regev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Guetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.amjcard.2015.10.036","article-title":"Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement","volume":"117","author":"Biancari","year":"2016","journal-title":"Am J Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.114.012525","article-title":"Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy","volume":"131","author":"Blackstone","year":"2015","journal-title":"Circulation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejcts.2010.11.039","article-title":"Trans-apical and trans-axillary percutaneous aortic valve implantation as alternatives to the femoral route: short- and middle-term results","volume":"40","author":"Taramasso","year":"2011","journal-title":"Eur J Cardiothorac Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1016\/j.jacc.2014.04.015","article-title":"Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience","volume":"63","author":"Greenbaum","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.jacc.2013.01.057","article-title":"Aortic access from the vena cava for large caliber transcatheter cardiovascular interventions: pre-clinical validation","volume":"61","author":"Halabi","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/eurheartj\/ehs255","article-title":"Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document","volume":"33","author":"Kappetein","year":"2012","journal-title":"Eur Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/ccd.26141","article-title":"How to perform transcaval access and closure for transcatheter aortic valve implantation","volume":"86","author":"Lederman","year":"2015","journal-title":"Catheter Cardiovasc Interv."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/jama.2015.1474","article-title":"Clinical outcomes at 1 year following transcatheter aortic valve replacement","volume":"313","author":"Holmes","year":"2015","journal-title":"JAMA."},{"key":"B11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13019-017-0638-9","article-title":"Transfemoral versus transapical approach for transcatheter aortic valve implantation: hospital outcome and risk factor analysis","volume":"12","author":"Ferrari","year":"2017","journal-title":"J Cardiothorac Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/ejcts\/ezy363","article-title":"Transfemoral versus transapical transcatheter aortic valve implantation: a single-centre experience","volume":"55","author":"Reents","year":"2019","journal-title":"Eur J Cardiothorac Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.jacc.2020.01.035","article-title":"Transcatheter electrosurgery: JACC state-of-the-art review","volume":"75","author":"Khan","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jacc.2016.10.024","article-title":"Transcaval access and closure for transcatheter aortic valve replacement: a prospective investigation","volume":"69","author":"Greenbaum","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B15","first-page":"463","article-title":"Comparative intermediate-term outcomes of subclavian and transcaval access for transcatheter aortic valve replacement","volume":"32","author":"Long","year":"2020","journal-title":"J Invasive Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.athoracsur.2018.04.029","article-title":"Transcatheter aortic valve replacement: comparing transfemoral, transcarotid, and transcaval access","volume":"106","author":"Paone","year":"2018","journal-title":"Ann Thorac Surg."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.731639\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T05:15:15Z","timestamp":1632287715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.731639\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":16,"alternative-id":["10.3389\/fcvm.2021.731639"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.731639","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"article-number":"731639"}}